SCHEMBL14060372

SCHEMBL14060372

Clc1ccc(-c2c[nH]c(Cc3cccs3)n2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.50
SMN1; SMN2 Q16637 6/20 0.43
LMNA P02545 5/20 0.43
ALDH1A1 P00352 4/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
PKM P14618 1/20 0.43
STAT6 P42226 1/20 0.43
HIF1A Q16665 1/20 0.43
TSHR P16473 1/20 0.43
ADRA1D P25100 2/20 0.42
MAPT P10636 3/20 0.40
HTT P42858 2/20 0.40
HSD17B10 Q99714 2/20 0.40
GPR55 Q9Y2T6 1/20 0.40
MAPK1 P28482 1/20 0.40
KDM4E B2RXH2 2/20 0.39
PNP P00491 1/20 0.37
CDK4 P11802 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14060621 0.88 LMNA (0.42) POLBSMN1; SMN2LMNAALDH1A1MEN1
SCHEMBL14060010 0.87 LMNA (0.49) POLBSMN1; SMN2LMNAALDH1A1MEN1
SCHEMBL14059775 0.86 POLB (0.42) POLBSMN1; SMN2LMNATSHRADRA1D
SCHEMBL14060378 0.86 LMNA (0.41) POLBSMN1; SMN2LMNAALDH1A1L3MBTL1
SCHEMBL31305555 0.82 LMNA (0.45) SMN1; SMN2LMNAALDH1A1MEN1KMT2A
SCHEMBL14060265 0.82 LMNA (0.45) SMN1; SMN2LMNAALDH1A1MEN1KMT2A
SCHEMBL14060497 0.82 POLB (0.47) POLBSMN1; SMN2LMNAALDH1A1PKM
SCHEMBL31305484 0.82 POLB (0.47) POLBSMN1; SMN2LMNAALDH1A1PKM
SCHEMBL31305534 0.82 POLB (0.42) POLBSMN1; SMN2LMNAALDH1A1L3MBTL1
SCHEMBL14059788 0.82 POLB (0.42) POLBSMN1; SMN2LMNAALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250215572-A1 SURFACE TREATMENT AGENT FOR COPPER OR COPPER ALLOY SHIKOKU CHEMICALS CORPORATION (JP) 2025-07-03 US disclosed
EP-4506488-A1 SURFACE TREATMENT AGENT FOR COPPER OR COPPER ALLOY Shikoku Chemicals Corporation (JP) 2025-02-12 EP disclosed
CN-118922584-A Surface treating agent for copper or copper alloy 四国化成工业株式会社 2024-11-08 CN disclosed
WO-2023190263-A1 SURFACE TREATMENT AGENT FOR COPPER OR COPPER ALLOY 四国化成工業株式会社 2023-10-05 WO disclosed
US-10398028-B2 Surface treating composition for copper and copper alloy and utilization thereof SHIKOKU CHEMICALS CORPORATION (JP) 2019-08-27 US disclosed
US-20170064823-A1 SURFACE TREATING COMPOSITION FOR COPPER AND COPPER ALLOY AND UTILIZATION THEREOF SHIKOKU CHEMICALS CORPORATION (JP) 2017-03-02 US disclosed
US-9532493-B2 Surface treating composition for copper and copper alloy and utilization thereof SHIKOKU CHEMICALS CORPORATION (JP) 2016-12-27 US disclosed
CN-103547706-B Surface treatment composition for copper and copper alloy and use thereof 四国化成工业株式会社 2016-09-28 CN disclosed
EP-2714962-B1 SURFACE TREATING COMPOSITION FOR COPPER AND COPPER ALLOY AND UTILIZATION THEREOF SHIKOKU CHEM (JP) 2015-07-08 EP disclosed
US-20140097231-A1 SURFACE TREATING COMPOSITION FOR COPPER AND COPPER ALLOY AND UTILIZATION THEREOF SHIKOKU CHEMICALS CORPORATION (JP) 2014-04-10 US disclosed
CN-103547706-A Surface treatment composition for copper and copper alloy and use thereof SHIKOKU CHEM 2014-01-29 CN disclosed
WO-2012161341-A1 SURFACE TREATING COMPOSITION FOR COPPER AND COPPER ALLOY AND UTILIZATION THEREOF SHIKOKU CHEMICALS CORPORATION (JP) 2012-11-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10398028-B2 Surface treating composition for copper and copper alloy and utilization thereof SOD1, SOD3, AOC3 POLB 1913/4885SMN1; SMN2 310/4885LMNA 4558/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.